Intracellular protein interactionsXigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland. Dr. Christophe Bonny, CEO and co-founder, is a renowned molecular biologist with over a decadeâ€™s...
Founded in 2002
Total money raised: $41M
Xigen at CrunchBase
Xigen raised $20M in a Series B round from Tilocor Life Science
Xigen was founded in 2002